Dose-response analysis in risk assessment: Evaluation of behavioral specificity

Environmental Health Perspectives

Volumn 104, Issue SUPPL. 2, 1996, Pages 391-396

  Glowa, John R ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Drug abuse; GBR 12909; Neurotoxicology; Rhesus monkeys; Risk assessment; Schedule controlled behavior

Indexed keywords

COCAINE; VANOXERINE;

ANIMAL EXPERIMENT; BEHAVIOR; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABUSE; DRUG EFFECT; HUMAN; METHODOLOGY; MONKEY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROBABILITY; RHESUS MONKEY; RISK ASSESSMENT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029999232     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.96104s2391     Document Type: Conference Paper

References (36)

1. Barnes G, Dourson M. Reference dose (RfD): description and use in health risk assessments. Reg Toxicol Pharmacol 8:471-486 (1988).
2. Crump KS. A new method for determining allowable daily intakes. Fundam Appl Toxicol 4:854-871 (1984).
3. Dews PB. On the assessment of risk. In: Developmental Behavioral Pharmacology (Krasnegor N, Gray J, Thompson T, eds). Hillsdale, NJ:Lawrence Erlbaum, 1986;53-65.
4. Dews PB. Some general problems in behavioral toxicology. In: Neurobehavioral Toxicology (Annau Z, ed), Baltimore:The Johns Hopkins University Press, 1986;424-434.
5. Dourson ML. New approaches in the derivation of acceptable daily intake (ADI). Comments Toxicol 1:35-48 (1986).
6. Glowa JR, MacPhail RC. Dose-response models for quantitative risk assessment in neurotoxicology. In: Handbook of Neurotoxicology, Vol 3: Approaches and Methodologies (Chang L, Tilson H, eds). New York:Raven Press, 1995;777-787.
7. McMillan DE. Risk assessment for neurobehavioral toxicity. Environ Health Perspect 76:155-161 (1987).
8. Raffaele KC, Rees DC. Neurotoxicology dose/response assessment for several cholinesterase inhibitors: use or uncertainty factors. Neurotoxicology 11:237-256 (1990).
9. Weiss B. Neurobehavioral toxicity as a basis for risk assessment. Trends Pharmacol Sci 91:59-62 (1988).
10. National Research Council. Environmental Neurotoxicology. Washington:National Academy Press (1992).
11. Cote I, Rees DC, Glowa JR. An introduction to the principles of risk assessment. In: The Vulnerable Brain and Environmental Risks, Vol 3: Toxins in Air and Water (Isaacson R, Jensen K, eds). New York:Plenum Press, 1994;183-207.
12. Barrett JE. Effects of alcohol, chlordiazepoxide, cocaine and pentobarbital on responding maintained under fixed-interval schedules of food or shock presentation. J Pharmacol Exp Ther 196:605-615 (1976).
13. Wood RW. Stimulus properties of inhaled substances: an update. In: Nervous System Toxicology (Mitchell CL, ed). New York:Raven Press 1982;199-212.
14. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd ed rev. Washington:APA Press, 1987.
15. Nestler EJ. Molecular mechanisms of drug addiction. J Neurosci 12:2439-2450 (1992).
16. Balster RL. Drug abuse potential evaluation in animals. Br J Addict 86:1549-1558 (1991).
17. Aigner T, Balster RL. Choice behavior in rhesus monkeys: cocaine versus food. Science 201:534-535 (1978).
18. Koob GF, Bloom FE. Cellular and molecular mechanisms of drug dependence. Science 242:715-723 (1988).
19. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237:1219-1223 (1987).
20. Peck AW, Hamilton M. Psychopharmacology of bupropion in normal volunteers. J Clin Psychiat 44:202-205 (1983).
21. Bergman J, Madras BK, Johnson SE, Spealman RD. Effects of cocaine and related drugs in nonhuman primates: III. Selfadministration by squirrel monkeys. J Pharmacol Exp Ther 251:150-155(1989).
22. Rothman RB. High affinity dopamine reuptake blockers as potential cocaine antagonists: a strategy for drug development. Life Sci 46:PL17-21 (1990).
23. Søgaard U, Michalow J, Butler B, Lund Laursen A, Ingersen SH, Skrumsager BK, Rafaelsen O. A tolerance study of single and multiple dosing of the selective dopamine uptake inhibitor GBR 12909 in healthy subjects. J Int Clin Psychopharmacol 5:237-251 (1990).
24. Glowa JR, DeWeese J, Natale ME, Holland JJ, Dews PB. Behavioral toxicology of volatile organic solvents: I. Methods: acute effects of toluene. J Environ Pathol Toxicol Oncol 6:153-168 (1986).
25. Glowa JR. Behavioral toxicity of n-octane. In: Advances in Modern Environmental Toxicology, Vol 6 (Mehlman MA, ed). Princeton, NJ:Princeton Scientific Publishers, 1984;245-253.
26. Glowa JR, Dews PB. Behavioral toxicology of volatile organic solvents: IV. Comparisons of the behavioral effects of acetone, methyl ethyl ketone, ethyl acetate, carbon disulfide, and toluene of the responding of mice. J Am Coll Toxicol 6:461-469 (1987).
27. Glowa JR. Behavioral toxicology of volatile organic solvents: V. Comparisons of the behavioral and neuroendocrine effects among n-alkanes. J Am Coll Toxicol 10:639-646 (1992).
28. Glowa JR. A comparison of dose-effect based risk assessment methods. Neurosci Biobehav Rev 15:153-158 (1991).
29. Rees DC, Glowa JR. Extrapolations to humans for neurotoxicants. In: The Vulnerable Brain and Environmental Risks, Vol 3: Toxins in Air and Water (Isaacson R, Jensen K, eds). New York:Plenum Press, 1994;207-230.
30. Glowa JR, Wojnicki FHE, Matecka D, Bacher J, Mansbach RS, Balster RL, Rice KC. Effects of dopamine reuptake inhibitors on food and cocaine maintained responding: I. Dependence on unit dose of cocaine. Exp Clin Psychopharmacol 3:219-231 (1995).
31. Glowa JR, Wojnicki FH, Matecka D, Rice K, Rothman RB. Effects of dopamine reuptake inhibitors on food and cocaine maintained responding: II. Comparisons of effects of psychomotor stimulants and subchronic effects. Exp Clin Psychopharmacol 3:231-239 (1995).
32. Wojnicki FHE, Bacher JD, Glowa JR. The use of subcutaneous vascular access port in rhesus monkeys. Lab Anim Med 44:491-494 (1994).
33. Gaddum JH. Lognornal distributions. Nature 156:463-466 (1945).
34. Crump KS, Allen BC, Faustman EM. The Use of the Benchmark Dose Approach in Health Risk Assessment. Final report. Washington:U.S. Environmental Protection Agency, 1992.
35. Wood RW, Cox CC. A repeated-measures approach to the detection of the minimal acute effects of toluene. Toxicology 6:221 (1986).
36. Corwin R, Schuster CR. Anorectic specificity as measured in a choice paradigm in rhesus monkeys. Pharmacol Biochem Behav 45:131-141 (1993).